Minimally invasive procedure effective for treating snoring

Oct 05, 2009

Radiofrequency ablation, a procedure that uses heat to shrink the tissue of the soft palate, is an effective and minimally invasive procedure that can be used to treat patients who snore.

In a paper presented at the 2009 American Academy of Otolaryngology - Head and Neck Foundation (AAO-HNSF) Annual Meeting & OTO EXPO in San Diego, researchers discussed treatment of primary in a prospective trial in a prospective study of 60 patients.

They sought to assess the three-year efficacy and morbidity of combined radiofrequency of the soft palate and partial uvulectomy.

Due to its minimally invasive character, significant improvement of primary snoring (snoring without sleep apnea), and low postoperative complication rates, radiofrequency surgery of the soft palate in general has become widespread. Nevertheless, the long-term clinical efficacy of radiofrequency surgery of the soft palate in primary snoring was limited.

Compared with the preoperative snoring score, the severity of snoring was reduced after two treatment sessions of combined radiofrequency. Seventy-six percent of the patients were satisfied to receive this operative treatment, after three-year follow-up.

Primary snoring may be an early predictor for people who will eventually develop obstructive sleep apnea. In contrast to obstructive , no generally accepted gold standard is available for the treatment of primary snoring.

The researchers noted that prior to their study long-term research results surrounding radiofrequency surgery of primary snoring were limited. Results of the current study may be able to guide physicians and in choosing effective treatment options for snoring.

Source: American Academy of Otolaryngology

Explore further: Doctors' checklist could help decrease length of COPD patients' hospital stay

Related Stories

Snoring runs in families, study finds

Apr 11, 2006

Children whose parents snore have a three-fold increased risk of being noisy sleepers, a study at Cincinnati Children's Hospital has found.

Recommended for you

'Ebola will return', veteran scientist warns

2 hours ago

Congolese expert Jean-Jacques Muyembe may be little known to the public, but he has been one of the world's top Ebola investigators since the first epidemic erupted in central Africa in 1976.

Score IDs patients with upper extremity DVT at low risk

17 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

May 29, 2015

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

May 29, 2015

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.